Cite
HARVARD Citation
Anstensrud, A. et al. (2019). Rationale for the ASSAIL-MI-trial: a randomised controlled trial designed to assess the effect of tocilizumab on myocardial salvage in patients with acute ST-elevation myocardial infarction (STEMI). Open heart. 6 (2), p. . [Online].